Polypurine reverse hoogsteen hairpins as a therapeutic tool for SARS-CoV-2 infection
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.107884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Carlos J Ciudad und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry & Physiology, School Pharmacy and Food Sciences, Universitat de Barcelona, Barcelona, Spain; Institut de Nanociencia i Nan…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Virus Replication, COVID-19 Drug Treatment. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Marathon Foundation of Tv3, Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Although the COVID-19 pandemic was declared no longer a global emergency by the World Health Organization in May 2023, SARS-CoV-2 is still infecting people across the world. Many therapeutic oligonucleotides such as ASOs, siRNAs, or CRISPR-based systems emerged as promising antiviral strategies for the treatment of SARS-CoV-2. In this work, we explored the inhibitory potential on SARS-CoV-2 replication of Polypurine Reverse Hoogsteen Hairpins (PPRHs), CC1-PPRH, and CC3-PPRH, targeting specific polypyrimidine sequences within the replicase and Spike regions, respectively, and previously validated for COVID-19 diagnosis. Both PPRHs are bound to their target sequences in the viral genome with high affinity in the order of nM. In vitro, both PPRHs reduced viral replication by more than 92% when transfected into VERO-E6 cells 24 h prior to infection with SARS-CoV-2. In vivo intranasal administration of CC1-PPRH in K18-hACE2 mice expressing the human ACE receptor protected all the animals from SARS-CoV-2 infection. The properties of PPRHs position them as promising candidates for the development of novel therapeutics against SARS-CoV-2 and other viral infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry & Physiology, School Pharmacy and Food Sciences, Universitat de Barcelona, Barcelona, Spain; Institut de Nanociencia i Nanotecnologia (IN2UB), Universitat de Barcelona, Barcelona, Spain. Elect…
- Department of Biochemistry & Physiology, School Pharmacy and Food Sciences, Universitat de Barcelona, Barcelona, Spain; Institut de Nanociencia i Nanotecnologia (IN2UB), Universitat de Barcelona, Barcelona, Spain.
- Centro de Investigación en Sanidad Animal-CISA, INIA, CSIC, Madrid, Spain.
- Institute for Advanced Chemistry of Catalonia, CSIC, Barcelona, Spain; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Madrid, Spain.
- Institute of Neurosciences, Universitat Autònoma de Barcelona, Barcelona, Spain.
Förderung
- Marathon Foundation of Tv3
- Ministerio de Ciencia e Innovación
Zitieren
APA
Ciudad, C. J., Valiuska, S., Rojas, J. M., Nogales-Altozano, P., Aviñó, A., Eritja, R., Chillón, M., Sevilla, N., & Noé, V. (2024). Polypurine reverse hoogsteen hairpins as a therapeutic tool for SARS-CoV-2 infection. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107884
Vancouver
Ciudad CJ, Valiuska S, Rojas JM, Nogales-Altozano P, Aviñó A, Eritja R, et al. Polypurine reverse hoogsteen hairpins as a therapeutic tool for SARS-CoV-2 infection. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107884
BibTeX
@article{Ciudad2024,
author = {Ciudad, Carlos J and Valiuska, Simonas and Rojas, José Manuel and Nogales-Altozano, Pablo and Aviñó, Anna and Eritja, Ramón and Chillón, Miguel and Sevilla, Noemí and Noé, Verónique},
title = {Polypurine reverse hoogsteen hairpins as a therapeutic tool for SARS-CoV-2 infection},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.107884}
}
EUVIMED